Aspects of clinical psychiatric research on depot neuroleptics. The presentation of two double-blind trials with cis (z) -clopenthixol decanoate and a withdrawal study in schizophrenics
Dencker, S.J.; Elgen, K.
Acta Psychiatrica Scandinavica. Supplementum 279: 5-9
1980
ISSN/ISBN: 0065-1591 PMID: 6996425 Document Number: 159429
Document emailed within 1 workday
Related Documents
Eufe, R.; Wegener, G. 1979: Double-blind comparison of 2 depot neuroleptics (perphenazine enanthate and flupentixol decanoate) in chronic schizophrenia Der Nervenarzt 50(8): 534-539Bell, D.S. 1989: Topics in clinical research. III. The importance of randomized, double-blind procedures in clinical trials Clinical Therapeutics 11(5): 565-567
Walker, C.A. 1983: A double-blind comparative trial of the decanoates of clopenthixol and fluphenazine in the treatment of chronic schizophrenic out-patients Pharmatherapeutica 3(5): 289-293
Muth, H.; Issmeier, G. 1980: Weight loss by treatment with Fugoa depot. Results of a double blind study Therapie der Gegenwart 119(10): 1173-1183
Benson, C.A.; Williams, P.L.; Cohn, D.L.; Becker, S.; Hojczyk, P.; Nevin, T.; Korvick, J.A.; Heifets, L.; Child, C.C.; Lederman, M.M.; Reichman, R.C.; Powderly, W.G.; Notario, G.F.; Wynne, B.A.; Hafner, R. 2000: Clarithromycin or rifabutin alone or in combination for primary prophylaxis of Mycobacterium avium complex disease in patients with AIDS: A randomized, double-blind, placebo-controlled trial. The AIDS Clinical Trials Group 196/Terry Beirn Community Programs for Clinical Research on AIDS 009 Protocol Team Journal of Infectious Diseases 181(4): 1289-1297
Bridges-Webb, C. 1984: Clinical trials. Controlled or double blind? Australian Family Physician 13(9): 680
Kabes, J.; Balon, R.; Papezová, H. 1986: Maintenance therapy using clopenthixol decanoate in schizophrenic patients Ceskoslovenska Psychiatrie 82(3-4): 189-194
Chhaparwal, M.; Saraf, M.L. 1998: Double-blind placebo--controlled trial of nandrolone decanoate in postmenopausal osteoporosis Indian Journal of Medical Sciences 52(6): 236-238
Bozza, A.E.; Guimarães, F.J.; de Carvalho, F.J.; Santos, L.C.; Pellon, F.M.; de Castro, R.F.; Balbuena, R.R. 1984: Comparative double-blind, randomized, crossover study controlled with placebo, of the efficacy of depot nifedipine in patients refractory to basic antihypertensive therapy Arquivos Brasileiros de Cardiologia 43(3): 213-217
Freeman, H. 1973: A double-blind comparison of mesoridazine and chlorpromazine in chronic schizophrenics Diseases of the Nervous System 34(6): 289-293
Silversides, A. 2011: Withdrawal of clinical trials policy by Canadian research institute is a "lost opportunity for increased transparency" Bmj 342: D2570
Chin, C.N.; Hamid, A.R.; Philip, G.; Ramlee, T.; Mahmud, M.; Zulkifli, G.; Loh, C.C.; Zakariah, M.S.; Norhamidah, M.S.; Suraya, Y.; Roslan, K.A.; Chandramohan, P.; Cheah, Y.C.; Leonard, A.O. 1998: A double blind comparison of zuclopenthixol acetate with haloperidol in the management of acutely disturbed schizophrenics Medical Journal of Malaysia 53(4): 365-371
John, T.Jacob.; Jain, H.; Ravishankar, K.; Amaresh, A.; Verma, H.; Deshpande, J.; Pallansch, M.A.; Singh, A.Pal.; Sreevatsava, M.; Burton, A.; Malankar, P.; Chatterjee, A.; Sutter, R.W. 2011: Monovalent type 1 oral poliovirus vaccine among infants in India: report of two randomized double-blind controlled clinical trials Vaccine 29(34): 5793-5801
Gallo, S.; Dibildox, M.; Moguel, A.; Di Silvio, M.; Rodríguez, F.; Almaguer, I.; García, C. 1998: Clinical superiority of pantoprazole over ranitidine in the treatment of reflux esophagitis grade Ii and III. a prospective, double-blind, double-placebo study. Mexican clinical experience. Mexican Pantoprazole Study Group Revista de Gastroenterologia de Mexico 63(1): 11-16
Macìas, G.; Merki-Feld, G.S.; Parke, S.; Mellinger, U.; Serrani, M. 2013: Effects of a combined oral contraceptive containing oestradiol valerate/dienogest on hormone withdrawal-associated symptoms: results from the multicentre, randomised, double-blind, active-controlled HARMONY Ii study Journal of Obstetrics and Gynaecology: the Journal of the Institute of Obstetrics and Gynaecology 33(6): 591-596
Bjørndal, F.; Lauritsen, B.; Lyngbye, J.; Waarst, S. 1979: Serum creatine kinase in patients treated with depot neuroleptics. a pilot study Ugeskrift for Laeger 141(51): 3514-3516
Lebranchu, Y.; Aubert, P.; Bayle, F.; Bedrossian, J.; Berthoux, F.; Bourbigot, B.; Buchler, M.; Chalopin, J.M.; Deteix, P.; Glotz, D.; Huraut De Ligny, B.; Kessler, M.; Lang, P.; Lefrancois, N.; Le Pogamp, P.; Moulin, B.; Mourad, G.; Olmer, M.; Sraer, J.D.; Touchard, G.; Toupance, O.; Wolf, P.; Puget, S. 2000: Could steroids be withdrawn in renal transplant patients sequentially treated with ATG, cyclosporine, and cellcept? One-year results of a double-blind, randomized, multicenter study comparing normal dose versus low-dose and withdrawal of steroids. M 55002 French Study Group Transplantation Proceedings 32(2): 396-397
Castaigne, J.P. 1985: Triella ― Etude clinique multicentrique française menée en double aveugle - Triella French multicentric clinical study lead in double blind Contraception Fertilite Sexualite (1973) 13(1): 445-453
Gillmer, R.E. 1973: Benzoctamine and oxazepam in the management of alcohol withdrawal states. Comparison by double-blind trial South African Medical Journal 47(47): 2267-2268
Soni, S.D.; Tench, D.; Ashwood, T.J.; Movin, G. 1990: Pharmacokinetics of an oral controlled release formulation of remoxipride: a double-blind, crossover comparison with conventional formulation in chronic schizophrenics Acta Psychiatrica Scandinavica. Supplementum 358: 45-47